Back to all articles Call for Experts − WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases
Deadline: 16 July 2022
Mon, Jun 27, 2022

Call for Experts − WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases Deadline: 16 July 2022

                                    

The World Health Organization (WHO) is seeking experts to serve as members of the Strategic and Technical Advisory Group for Neglected Tropical Diseases. This “Call for Experts” notice provides information about the advisory group in question, the expert profiles being sought, the process to express interest, and the process of selection.

Background

The Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) is the main advisory body to World Health Organization in this field.

NTDs are a diverse set of bacterial, viral, parasitic, fungal and noncommunicable diseases and disease groups that disproportionately affect populations living in poverty, predominantly in tropical and subtropical areas. Twenty diseases and disease groups are currently included in the NTD portfolio, and currently more than one billion people are affected.

STAG-NTD advises and makes policy and strategic recommendations to WHO, based on independent reviews of progress made and challenges faced by programmes and partners, with the aim of facilitating the achievement of the targets and milestones set by the NTD road map 2021–2030

Functions of the Strategic and Technical Advisory Group for Neglected Tropical Diseases

In its capacity as an advisory body to WHO, the STAG-NTD shall have the following functions:

  1. To provide to WHO independent evaluation of the adequacy of progress towards the targets and milestones of the NTD road map 2021–2030;
  2. To review, and make recommendations to WHO for overcoming, challenges to achieving the targets and milestones of the NTD road map 2021–2030;
  3. To review, and make recommendations to WHO on increasing, the adoption of the three fundamental shifts in approach to tackling NTDs specified in the NTD road map 2021–2030

Operations of the Strategic and Technical Advisory Group for Neglected Tropical Diseases

The STAG-NTD will normally meet in person once a year at WHO Headquarters in Geneva, Switzerland, usually for 2-3 days.   Depending on the issues at stake, additional interim meetings may be organized in the course of the year.  The working language of the STAG-NTD will be English.

Who can express interest?

The STAG-NTD will be multidisciplinary, with members having a range of technical knowledge, skills and experience relevant to NTDs and of the challenges faced by programmes and partners within the context of health systems in NTD-endemic countries.  Up to approximately 20 members may be selected.

WHO welcomes expressions of interest from individuals with knowledge, skills and experience in:

  • Health systems and programme delivery
  • Health policy
  • Social science
  • One health
  • Vector control
  • Water and sanitation
  • Health economics
  • Pricing, procurement, needs estimation and/or regulation of medicines;
  • Country-level planning and implementation of cross-cutting activities.

Submitting your expression of interest

To register your interest in being considered for the [name of the advisory group], please submit the following documents by 24:00h (midnight) Geneva time on 16 July 2022 to aimel@who.int using the subject line “Expression of interest for the STAG-NTD”.

  • A cover letter, indicating your motivation to apply and outlining how you satisfy the selection criteria. Please note that, if selected, membership will be in a personal capacity. Therefore do not use the letterhead or other identification of your employer);
  • Your curriculum vitae; and
  • A signed and completed Declaration of Interests (DOI) form for WHO Experts, available at https://www.who.int/about/ethics/declarations-of-interest.

After submission, your expression of interest will be reviewed by WHO.  Due to an expected high volume of interest, only selected individuals will be informed.

Important information about the selection processes and conditions of appointment

Members of WHO advisory groups (AGs) must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of an AG is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).

All AG members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts (https://www.who.int/about/ethics/declarations-of-interest). AG members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant AG.

The selection of members of the AG will be made by WHO in its sole discretion, taking into account  the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations .The selection of AG members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.

If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of an AG will be subject to the proposed member returning to WHO the countersigned copy of these two documents.

WHO reserves the right to accept or reject any expression of interest, to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO's action. WHO may also decide, at any time, not to proceed with the establishment of the AG, disband an existing AG or modify the work of the AG.

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO may publish the names and a short biography of the selected individuals on the WHO internet.

AG members will not be remunerated for their services in relation to the AG or otherwise. Travel and accommodation expenses of AG members to participate in AG meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.

The appointment will be limited in time as indicated in the letter of appointment.

If you have any questions about this “Call for experts”, please write to aimel@who.int well before the applicable deadline.


Articles

Featured Tue, Mar 3, 2026

13Th Edition Of The Edctp Forum To Take Place In Madrid, Spain, From 5 To 9 April 2027

We are delighted to announce that the 13th edition of the EDCTP Forum will be celebrated on 5-9 April 2027, at IFEMA Palacio Municipal in Madrid, Spain.  

 

The event will be co-hosted by the Instituto de Salud Carlos III (ISCIII) under the Spanish Ministry of Science, Innovation and Universities and the Fundación CSAI (FCSAI) under the Ministry of Health, and is co-organised by Global Health EDCTP3 and the EDCTP Association

 

Over the past two decades, the biennial European & Developing Countries Clinical Trials Partnership (EDCTP) Forum has evolved to become a cornerstone event for global health research, bringing together leading voices advancing the fight against infectious diseases in sub-Saharan Africa. It showcases the latest scientific breakthroughs, highlights impactful capacity-building efforts, and creates a space for vibrant cross-regional collaboration.

 

The EDCTP Forum 2027 expects to convene 1,500 participants and stakeholders, from researchers, universities and clinicians to governments, regional bodies, civil society, regulators, and public and private R&D partners, drawing participation primarily from Africa and Europe.  


Read more »

Read more
Tue, Mar 3, 2026

Dr Tuelo Mogashoa Becomes First Tagendi Phd Graduate

Botswana-born scientist Dr Tuelo Mogashoa, a PhD Fellow in the ‘Addressing Gender and Diversity Regional Gaps in Clinical Research Capacity’ (TAGENDI) programme, has successfully defended her PhD in Molecular Biology (Tuberculosis Genomics) at Stellenbosch University. Her virtual oral examination, held on 12 January 2025, marked the culmination of years of research and training.

Her doctoral thesis, titled “Rifampicin- resistant tuberculosis: an emerging threat to human health in Botswana,” addresses one of the most pressing challenges in TB control.

Dr Mogashoa is the first of seven PhD fellows from the inaugural TAGENDI cohort to complete her doctoral studies. The TAGENDI fellowship, implemented under the Trials of Excellence in Southern Africa (TESA) Network, is part of a dedicated PhD fellowship scheme launched by EDCTP2 in 2020 to support women in health research across sub-Saharan Africa. Coordinated by the EDCTP Networks of Excellence, the initiative received funding from the UK National Institute for Health and Care Research (Department of Health and Social Care).

As part of her PhD requirements, Dr Mogashoa was expected to produce four manuscripts, with at least two accepted in peer-reviewed journals. She has exceeded this requirement, publishing three peer-reviewed articles from her doctoral work, with a fourth manuscript currently under review.

Her journey highlights the transformative impact of long-term investment in research training, mentorship, and gender equity. As she moves into the next phase of her career, her work promises to make a meaningful contribution to improving TB diagnosis, treatment, and control.


More information:



Read more
Tue, Mar 3, 2026

Prof. Novel Chegou Elected As Fellow Of The African Academy Of Sciences

Prof. Novel Chegou, EDCTP Senior Fellow and Acting Head of the Division of Immunology at the Faculty of Medicine and Health Sciences, Stellenbosch University, has been elected as a Fellow of the African Academy of Sciences. This important achievement recognises his scientific leadership and impactful research on tuberculosis, particularly his work on biomarkers to improve diagnosis and patient care in resource-limited settings.

Read more »

Read more